M
Maureen Higgins
Researcher at University of Dundee
Publications - 53
Citations - 2741
Maureen Higgins is an academic researcher from University of Dundee. The author has contributed to research in topics: Quinone oxidoreductase & KEAP1. The author has an hindex of 20, co-authored 48 publications receiving 2037 citations. Previous affiliations of Maureen Higgins include University of St Andrews.
Papers
More filters
Journal ArticleDOI
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1.
Evanna L. Mills,Dylan G. Ryan,Hiran A. Prag,Dina Dikovskaya,Deepthi Menon,Zbigniew Zaslona,Mark P. Jedrychowski,Ana S. H. Costa,Maureen Higgins,Emily Hams,John Szpyt,Marah C. Runtsch,Martin S. King,Joanna F. McGouran,Roman Fischer,Benedikt M. Kessler,Anne F. McGettrick,Mark M. Hughes,Richard G. Carroll,Richard G. Carroll,Lee M. Booty,Lee M. Booty,Elena V. Knatko,Paul J. Meakin,Michael L.J. Ashford,Louise K. Modis,Gino Brunori,Daniel C. Sévin,Padraic G. Fallon,Stuart T. Caldwell,Edmund R.S. Kunji,Edward T. Chouchani,Christian Frezza,Albena T. Dinkova-Kostova,Albena T. Dinkova-Kostova,Richard C. Hartley,Michael P. Murphy,Luke A. J. O'Neill,Luke A. J. O'Neill +38 more
TL;DR: It is shown that itaconate is required for the activation of the anti-inflammatory transcription factor Nrf2 by lipopolysaccharide in mouse and human macrophages and that type I interferons boost the expression of Irg1 (also known as Acod1) and itaconates production.
Journal ArticleDOI
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator
Sonia Lain,Jonathan James Hollick,Johanna Campbell,Oliver D. Staples,Maureen Higgins,Mustapha Aoubala,Anna R. McCarthy,Anna R. McCarthy,Virginia Appleyard,Karen Murray,Lee Baker,Alastair M. Thompson,Joanne Mathers,Stephen J. Holland,Michael J. R. Stark,Georgia J. Pass,Julie A. Woods,David P. Lane,Nicholas J. Westwood +18 more
TL;DR: It is shown that tenovins act through inhibition of the protein-deacetylating activities of SirT1 and SirT2, two important members of the sirtuin family, and underscores the utility of these compounds as biological tools for the study of sIRTuin function as well as their potential therapeutic interest.
Journal ArticleDOI
Ribosomal protein S3: A multi-functional protein that interacts with both p53 and MDM2 through its KH domain.
Sridevi Yadavilli,Lindsey D. Mayo,Maureen Higgins,Sonia Lain,Sonia Lain,Vijay Hegde,Walter A. Deutsch +6 more
TL;DR: DNA pull-down assays using a 7,8-dihydro-8-oxoguanine duplex oligonucleotide as a substrate found that RPS3 acted as a scaffold for the additional binding of MDM2 and p53, suggesting that R PS3 interacts with important proteins involved in maintaining genomic integrity.
Journal ArticleDOI
Novel Cambinol Analogs as Sirtuin Inhibitors: Synthesis, Biological Evaluation, and Rationalization of Activity
Federico Medda,Rupert J. Russell,Maureen Higgins,Anna R. McCarthy,Johanna Campbell,Alexandra M. Z. Slawin,David P. Lane,Sonia Lain,Nicholas J. Westwood +8 more
TL;DR: Modifications to the core structure of cambinol are described by incorporation of substituents at the N1-position, which lead to increased potency and modified selectivity, which has been rationalized using molecular modeling techniques.
Journal ArticleDOI
KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients
Luisa Quinti,Sharadha Dayalan Naidu,Ulrike Träger,Xiqun Chen,Kimberly B. Kegel-Gleason,David Llères,Colúm Connolly,Vanita Chopra,Cho Low,Sébastien Moniot,Ellen Sapp,Adelaide Tousley,Petr Vodicka,Michael J. Van Kanegan,Linda S. Kaltenbach,Lisa A. Crawford,Matthew Fuszard,Maureen Higgins,James R. Miller,Ruth Farmer,Vijay Potluri,Susanta Samajdar,Lisa Meisel,Ningzhe Zhang,Andrew Snyder,Ross S. Stein,Steven M. Hersch,Lisa M. Ellerby,Eranthie Weerapana,Michael A. Schwarzschild,Clemens Steegborn,Blair R. Leavitt,Alexei Degterev,Sarah J. Tabrizi,Donald C. Lo,Marian DiFiglia,Leslie M. Thompson,Albena T. Dinkova-Kostova,Albena T. Dinkova-Kostova,Aleksey G. Kazantsev +39 more
TL;DR: The use of a unique chemical scaffold revealed that NRF2 activation responses were muted in HD patient-derived neural stem cells, suggesting increased susceptibility of this critical renewable cell population to oxidative stress in HD brain, and a muted NRf2 activation response in human HD Neural stem cells was discovered, which was restored by genetic correction of the disease-causing mutation.